Literature DB >> 1304701

Altered plasma lipid pattern in falciparum malaria.

S Mohanty1, S K Mishra, B S Das, S K Satpathy, D Mohanty, J K Patnaik, T K Bose.   

Abstract

Plasma levels of HDL, LDL, total cholesterol and triglycerides were measured in 60 patients with falciparum malaria (37 severe cases and 23 mild) and in 83 healthy individuals, to study malaria-induced changes in plasma lipids. Triglyceride levels were lower in the patients than in the controls but the difference was significant only for those with severe malaria (P < 0.001). In contrast, the levels of all the other plasma lipids were significantly higher (P < 0.001) in those with severe malaria than in those with mild malaria, and in the mild malaria cases compared with the controls. Initially LDL cholesterol was estimated by the Friedwald formula, but this gave negative values in a few cases of severe malaria. Plasma lipoproteins were therefore also measured by nephelometry; the estimated levels of S particles, corresponding to LDL, were then found to be lower in all malaria cases than in the controls (P < 0.001) but never negative. Interestingly, levels of L particles in the patients with severe malaria were significantly elevated compared with the other patients and controls (P < 0.001), indicating impaired metabolism of chylomicrons. Plasma albumin, considered a negative acute phase protein (i.e. its level decreases as a consequence of the acute phase response), was reduced significantly and was directly correlated to HDL cholesterol levels (r = 0.715 and r = 0.895, respectively) in both mild and severe malaria. Follow-up of 22 of the severe malaria cases three weeks after treatment indicated that, while triglycerides had returned to similar levels to those in the controls, total cholesterol levels were still elevated and could give misleading results if lipid profiles were used, immediately after malaria infection, to assess an individual's risk of developing atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1304701     DOI: 10.1080/00034983.1992.11812715

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  15 in total

1.  Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon.

Authors:  Marielle K Bouyou-Akotet; Michael Ramharter; Edgard Brice Ngoungou; Modeste Mabika Mamfoumbi; Mireille Pemba Mihindou; Michel A Missinou; Florian Kurth; Sabine Bélard; Selidji T Agnandji; Saadou Issifou; János L Heidecker; Sonja Trapp; Peter G Kremsner; Maryvonne Kombila
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

2.  Serum Lipids and Lipoproteins During Uncomplicated Malaria: A Cohort Study in Lambaréné, Gabon.

Authors:  Benjamin J Visser; Sophia G de Vries; Rieke Vingerling; Martin Gritter; Danielle Kroon; Lídia Ciudad Aguilar; Rik B J Kraan; Rosanne W Wieten; François Danion; Barbara Sjouke; Akim A Adegnika; Selidji T Agnandji; Peter G Kremsner; Thomas Hänscheid; Petra F Mens; Michèle van Vugt; Martin P Grobusch
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

3.  The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum.

Authors:  B Cenni; J Meyer; R Brandt; B Betschart
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

Review 4.  Cachexia in malaria and heart failure: therapeutic considerations in clinical practice.

Authors:  M E Onwuamaegbu; M Henein; A J Coats
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

5.  Hypertriglyceridemia as an indicator of the severity of falciparum malaria in returned travelers: a clinical retrospective study.

Authors:  Philippe Parola; Pierre Gazin; Fabien Patella; Sékéné Badiaga; Jean Delmont; Philippe Brouqui
Journal:  Parasitol Res       Date:  2004-02-12       Impact factor: 2.289

6.  Serum lipoproteins promote efficient presentation of the malaria virulence protein PfEMP1 at the erythrocyte surface.

Authors:  Sarah Frankland; Salenna R Elliott; Francisca Yosaatmadja; James G Beeson; Stephen J Rogerson; Akinola Adisa; Leann Tilley
Journal:  Eukaryot Cell       Date:  2007-07-20

7.  Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice.

Authors:  Vanessa C F Mosqueira; Philippe M Loiseau; Christian Bories; Philippe Legrand; Jean-Philippe Devissaguet; Gillian Barratt
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

8.  The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.

Authors:  Kesinee Chotivanich; Mathirut Mungthin; Ronnatrai Ruengweerayuth; Rachanee Udomsangpetch; Arjen M Dondorp; Pratap Singhasivanon; Sasithon Pukrittayakamee; Nicholas J White
Journal:  Malar J       Date:  2012-05-28       Impact factor: 2.979

Review 9.  Role of cholesterol in parasitic infections.

Authors:  Devendra Bansal; Harinderpal Singh Bhatti; Rakesh Sehgal
Journal:  Lipids Health Dis       Date:  2005-05-09       Impact factor: 3.876

10.  Increased fluidity and oxidation of malarial lipoproteins: relation with severity and induction of endothelial expression of adhesion molecules.

Authors:  Nathawut Sibmooh; Paveena Yamanont; Srivicha Krudsood; Wattana Leowattana; Gary Brittenham; Sornchai Looareesuwan; Rachanee Udomsangpetch
Journal:  Lipids Health Dis       Date:  2004-06-25       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.